BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21743285)

  • 1. [A case of ductal adenocarcinoma of the prostate treated with endocrine therapy and radiation therapy].
    Suzuki T; Shinbo H; Kurita Y; Furuse H; Mugiya S; Ozono S
    Hinyokika Kiyo; 2011 May; 57(5):261-4. PubMed ID: 21743285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
    Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
    Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure prostatic papillary adenocarcinoma with ductal features.
    Yamashita S; Inaba Y; Soma F; Katayama Y
    Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate.
    Tu WH; Jensen K; Freiha F; Liao JC
    Nat Clin Pract Urol; 2008 Jan; 5(1):55-8. PubMed ID: 18185514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study: ductal adenocarcinoma of the prostate.
    Dziuba K
    Urol Nurs; 2009; 29(6):422-4. PubMed ID: 20088233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostatic cancer in a young adult: a report of 2 cases].
    Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
    Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital].
    Nakamura K; Terada N; Kobayashi T; Sugino Y; Yamasaki T; Matsui Y; Imamura M; Okubo K; Kamba T; Yoshimura K; Ogawa O
    Hinyokika Kiyo; 2015 Dec; 61(12):487-91. PubMed ID: 26790762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A prostatic duct carcinoma difficult to distinguish from transitional cell carcinoma: a case report].
    Ushida H; Koizumi S; Okada Y
    Hinyokika Kiyo; 2004 Aug; 50(8):535-8. PubMed ID: 15471072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of mucinous adenocarcinoma of the prostate].
    Ishibashi Y; Kishida T; Yamaguchi T; Sugawara T; Satomi Y
    Hinyokika Kiyo; 1992 Apr; 38(4):463-7. PubMed ID: 1326881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of primary transitional cell carcinoma of the prostate].
    Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
    Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of prostate cancer that developed following transurethral resection of the prostate: diagnostic efficiency of diffusion-weighted images on magnetic resonance imaging].
    Ohzeki T; Mori Y; Katoh Y; Iguchi M; Yamasaki M
    Hinyokika Kiyo; 2010 May; 56(5):277-80. PubMed ID: 20519927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
    Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
    Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare histological patterns of prostatic ductal adenocarcinoma.
    Lee TK; Miller JS; Epstein JI
    Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.